Aviron Message Board - Msg: 3921743

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.375

+1.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: s jones who wrote (218)	4/1/1998 5:30:00 PM
From: SJS	Read Replies (1) of 645

Folks, Morgan Stanley initiated coverage today of AVIR with an OUTPERFORM rating. I think we could use it. The stock has been essentially flat (very narrow trading range) since September 1997. Enjoy. _________________ RESEARCH ALERT - Aviron started NEW YORK, April 1 (Reuters) - Morgan Stanley said Wednesday it initiated coverage of Aviron with an outperform rating. -- Aviron was seen as a pure-play vaccine company; Morgan expects it to file by midyear for U.S. Food and Drug Administration approval of a new flu vaccine. -- Worldwide sales for this vaccine were forecast as exceeding $500 million by 2002.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next